Search - tctmd.com

Displaying 621 - 640 of 778

Sort: Relevancy | Date

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Daily News

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Michael O'Riordan

January 29, 2019

News Daily News

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

Michael O'Riordan

January 21, 2019

News Daily News

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Michael O'Riordan

January 17, 2019

News Daily News

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Michael O'Riordan

January 11, 2019

News Daily News

Working Less, Earning Less: Stroke, MI, and Cardiac Arrest Have Long-term Labor Consequences

Michael O'Riordan

January 07, 2019

News Features

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

News Daily News

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Michael O'Riordan

December 24, 2018

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

News Daily News

FDA Touts Increased Oversight of Medical Device Makers

Michael O'Riordan

November 22, 2018

News Conference News AHA 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Michael O'Riordan

November 12, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Daily News

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Michael O'Riordan

November 09, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

Advertisement

One in Two Americans Have Cardiovascular Disease: AHA Stats

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Working Less, Earning Less: Stroke, MI, and Cardiac Arrest Have Long-term Labor Consequences

Top News in Prevention: 2018

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Better TAVR Outcomes With More Experienced Operators: New York Database

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

FDA Touts Increased Oversight of Medical Device Makers

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content